Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,416.00
Bid: 12,408.00
Ask: 12,410.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.016%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,416.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: PM Johnson confirms England lockdown easing on May 17

Mon, 10th May 2021 18:55

(Alliance News) - People in England will be able to hug loved ones, dine in restaurants and go on holiday abroad from next week in a "considerable step on the road back to normality", Prime Minister Boris Johnson has confirmed.

The move to the next stage of the road map out of lockdown on May 17 came as the Covid-19 alert level in the UK was downgraded after a "consistent" fall in cases, hospital admissions and deaths.

The prime minister set out a new approach to tackling the virus, giving people greater responsibility for their own choices on whether to observe social distancing measures with friends and family.

"Today we are taking a step towards that moment when we learn to live responsibly with Covid, when we cease eventually to rely on detailed Government edicts and make our own decisions," he said.

Confirmation that England would move to step three on the road map came from Johnson at a Downing Street press conference after a Cabinet meeting to sign off the change.

The prime minister said: "This unlocking amounts to a very considerable step on the road map to normality and I am confident that we will be able to go further."

The road map remained on track for the next stage on June 21 and Johnson promised that later this month the government would set out "what role there could be – if any – for certification and social distancing".

The government has been reviewing whether Covid status certification, recording whether people have had a vaccine or negative test result, could be used to help open up businesses and Johnson's comments could be a hint they are no longer a priority.

Johnson said the current data indicated that it might be possible to scrap the "one-metre plus" rule, something which would greatly increase flexibility for businesses to increase capacity.

From May 17:

– People will be able to meet outdoors in groups of up to 30.

– People will be able to meet indoors in groups of six, or two households.

– Pubs and restaurants will be able to serve customers indoors, although they will be limited to table service.

– Cinemas, museums, theatres and concert halls will be allowed to reopen although there will be capacity limits on large events.

– The "stay in the UK" restriction will lift and people will be able to travel to "green list" countries, such as Portugal although they are still being advised not to go to destinations on the amber list.

– Up to 30 people will be allowed at weddings, although dancing will still not be allowed, and the cap on the number of mourners attending funerals will be lifted, in line with the safe capacity of the venue.

– Secondary school pupils will no longer be told to wear face masks in class and communal areas.

– University students will return to campus for in-person lectures.

The easing of restrictions came after the UK's senior medics said the Covid-19 alert level should be lowered from "level 4" to "level 3", meaning that while the epidemic is in general circulation, transmission is no longer deemed to be high or rising exponentially.

But England's chief medical officer Professor Chris Whitty urged particular caution around the Indian variant which has been detected in increasing numbers in the UK.

From a low level "it has gone up very sharply" he said, warning that it was possibly more transmissible than the Kent variant which swept across the UK in the winter.

But "at this point in time our view is that it is less likely to be able to escape vaccination than some of the other variants".

Up to May 5, some 520 confirmed or probable cases of the Indian strain had been identified, an increase of 318 in a week.

The latest figures showed that up to May 9, 35.5 million people have had a first dose of vaccine, a rise of 100,626 on the previous day, while 17.9 million of those have now also had a second doses, an increase of 187,171.

A further four people died within 28 days of testing positive for Covid-19 as of Monday, bringing the UK total by that measure to 127,609.

The figures on the government dashboard showed none of the new deaths reported on Monday were in England, Scotland or Northern Ireland but there is often a lag in data following a weekend.

The government also said that, as of 0900 BST on Monday, there had been a further 2,357 lab-confirmed cases in the UK, bringing the total to 4.44 million.

Meanwhile, BioNTech SE has said its Covid-19 vaccine with Pfizer SE does not need to be tweaked to tackle variants of the virus currently in circulation.

But it said that it has a strategy to "address these variants should the need arise in the future".

In further positive news, analysis by Public Health England found a single dose of the AstraZeneca PLC vaccine reduces the risk of death with Covid-19 by approximately 80% – and two doses of Pfizer cut it by 97%.

By David Hughes, PA Political Editor

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.